epirubicin has been researched along with Retroperitoneal Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, J; Guo, W; Huang, M; Ji, D; Li, J; Liu, X; Peng, W; Sun, S; Wang, C; Yin, J; Yu, H; Zhao, X; Zhu, X | 1 |
| Hamano, A; Katoh, Y; Mikata, K; Nagashima, Y; Noguchi, S; Ohgo, Y; Takase, K; Yamashita, Y; Yumura, Y | 1 |
| Kosaka, A; Maruo, H | 1 |
1 trial(s) available for epirubicin and Retroperitoneal Neoplasms
| Article | Year |
|---|---|
Epirubicin combined with oxaliplatin and 5-day continuous infusion of 5-fluorouracil as a first-line treatment for metastatic gastric cancer: treatment outcomes and analysis of prognostic factors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Fluorouracil; Follow-Up Studies; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retroperitoneal Neoplasms; Retrospective Studies; Stomach Neoplasms; Survival Rate; Young Adult | 2015 |
2 other study(ies) available for epirubicin and Retroperitoneal Neoplasms
| Article | Year |
|---|---|
[Two cases of retroperitoneal liposarcoma arisen from perirenal fat tissue, which could not be diagnosed preoperatively].
Topics: Adipose Tissue; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Epirubicin; Humans; Kidney; Liposarcoma; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Retroperitoneal Neoplasms; Tomography, X-Ray Computed | 2004 |
[A case of liver metastasis from retroperitoneal leiomyosarcoma successfully treated by intra-arterial infusion chemotherapy of adriamycin or epirubicin using an implantable reservoir].
Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Leiomyosarcoma; Liver Neoplasms; Middle Aged; Prognosis; Retroperitoneal Neoplasms | 1993 |